Releaf, the UK’s fastest-growing medical hashish clinic, has introduced a landmark partnership with Glass Pharms, a pioneering UK-based hashish cultivator. This collaboration will introduce the primary domestically grown, balanced, and THC-bearing medical hashish flower to the UK market, out there solely by way of Releaf. Glass Pharms’ launch companion, Releaf, would be the first clinic to supply sufferers entry to domestically cultivated hashish cultivars. This vital milestone helps the expansion of the UK’s medical hashish trade whereas offering sufferers with a sustainable, high-quality, and constant provide of medicine.
Tim Kirby, managing director of Releaf, stated: “Releaf, by way of its partnership with Glass Pharms, brings the primary domestically grown medical hashish to the UK’s healthcare panorama, addressing the unmet healthcare wants of sufferers, and delivering a constant provide of high-quality CBPMs to UK sufferers whose situations can profit from this therapy.”
Glass Pharms’ state-of-the-art services make use of superior AI-controlled rising situations and laboratory services, making certain batch-to-batch consistency and adherence to the very best high quality requirements set by the MHRA and Dwelling Workplace. Moreover, their web carbon-negative cultivation course of makes use of roughly 40% of the facility in comparison with conventional indoor rising strategies.
“Releaf has a robust concentrate on affected person expertise with a superb proprietary know-how platform to allow it. The mixed providing is nice information for sufferers, notably those that care in regards to the atmosphere,” stated James Duckenfield, CEO of Glass Pharms.
Chloe Durrington, 26, suffers from endometriosis and is the primary affected person within the UK to be prescribed one among these cultivars, stated: “From an environmental standpoint, it feels good to know that my medicine hasn’t needed to journey throughout the globe to get to me. Plus, it provides me peace of thoughts that points with provide, which have till now been one of many important challenges for sufferers like me, are far much less probably if the hashish isn’t coming from abroad.”
Releaf’s proprietary HealthTech platform, which has seen over 16,000 individuals open an account since its launch on 1st February following 18 months of tech growth, will now characteristic a spread of six Releaf-branded cultivars. This medicine vary is simply out there by way of Releaf, additional enhancing the clinic’s differentiated service and distinctive worth for sufferers.
Leave a Reply